Immunovant Cash Flow Statement 2019-2024 | IMVT

Fifteen years of historical annual cash flow statements for Immunovant (IMVT).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$-259.34$-210.96$-156.73$-107.43$-66.39$-28.60
$0.23$0.19$0.13$0.07$0.02$0.01
$42.25$33.43$35.35$19.47$8.20$1.49
$42.48$33.62$35.48$19.54$8.23$1.50
$-4.58$11.76$-11.63$-0.60$0$0
$0$0$0$0$0$0
$5.46$-16.97$16.43$1.25$1.21$-0.88
$0.39$-21.68$0.96$-0.05$-2.82$-2.52
$2.63$-10.85$15.14$4.57$4.81$-1.45
$-214.23$-188.19$-106.11$-83.33$-53.36$-28.55
$-0.36$-0.20$-0.25$-0.21$-0.03$-0.05
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$-0.36$-0.20$-0.25$-0.21$-0.03$-0.05
$0$0$0$0$32.50$0
$0$0$200$-3.19$5.41$0
$0$0$200$-3.19$37.91$0
$478$71.16$0$386$0.00$14.91
$478$71.16$0$386$0.00$14.91
$0$0$0$0$0$0
$-6.01$-0.27$0.13$-0.14$109$20.67
$472$70.89$200$383$147$35.58
$259$-117.29$93.67$300$93.59$6.99
$41.12$32.30$34.24$18.82$6.96$1.31
$0$0$0$0$0$0